OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
48
Results
Show all
Save search
Copy query
Show results for
Unknown
(48)
Publication Date
Release Date
2021
(14)
2022
(11)
2025
(5)
2019
(5)
2020
(4)
2024
(2)
2015
(2)
2012
(2)
2011
(2)
2014
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis.
Not available
S-EPMC4533049
|
biostudies-literature
Cite
Urobiome Signatures of Recurrent Urinary Tract Infections in Adolescent Pregnancy: A Longitudinal Study.
Not available
S-EPMC12566430
|
biostudies-literature
Cite
Hemorrhage/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance.
Not available
S-EPMC7964764
|
biostudies-literature
Cite
Uric acid and unhealthy metabolic phenotype in Colombian children.
Not available
S-EPMC12928131
|
biostudies-literature
Cite
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623
|
biostudies-literature
Cite
Heterogeneity of prodromal Parkinson symptoms in siblings of Parkinson disease patients.
Not available
S-EPMC8423761
|
biostudies-literature
Cite
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Not available
S-EPMC7399713
|
biostudies-literature
Cite
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis.
Not available
S-EPMC9433956
|
biostudies-literature
Cite
Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy.
Not available
S-EPMC3136437
|
biostudies-literature
Cite
CD8+ NKs as a potential biomarker of complete response and survival with lenalidomide plus R-GDP in the R2-GDP-GOTEL trial in recurrent/refractory diffuse large B cell lymphoma.
Not available
S-EPMC10926187
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets